Low Blood Levels of LRG1 Before Radical Prostatectomy Identify Patients with High Risk of Progression to Castration-resistant Prostate Cancer-Reference-Cited by-同舟云学术

Low Blood Levels of LRG1 Before Radical Prostatectomy Identify Patients with High Risk of Progression to Castration-resistant Prostate Cancer

Published:2022-11 Issue: Volume:45 Page:68-75
ISSN:2666-1683
Container-title:European Urology Open Science
language:en
Short-container-title:European Urology Open Science

Author:

Guldvik Ingrid Jenny,Braadland Peder Rustøen,Sivanesan Shivanthe,Ramberg Håkon,Kristensen Gitte,Tennstedt Pierre,Røder Andreas,Schlomm Thorsten,Berge Viktor,Eri Lars Magne,Lilleby Wolfgang,Mills Ian G.,Taskén Kristin Austlid

Funder

University Hospitals

Norges Forskningsråd

Helse Sør-Øst RHF

Publisher

Elsevier BV

Subject

Urology

Reference23 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer;Cornford;Eur Urol,2021

3. Update on systemic prostate cancer therapies: management of metastatic castration-resistant prostate cancer in the era of precision oncology;Nuhn;Eur Urol,2019

4. Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer;Davis;N Engl J Med,2019

5. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial;James;Lancet,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic interrogation of immune-oncology-related proteins in patients with locally advanced prostate cancer undergoing androgen deprivation and intensity-modulated radiotherapy;World Journal of Urology;2024-02-22

2. The Potential of Extracellular Matrix- and Integrin Adhesion Complex-Related Molecules for Prostate Cancer Biomarker Discovery;Biomedicines;2023-12-28